Argenx Se ARGX
NASDAQ ARGX
$929.07 +34.30 (+3.83%)
As of: Nov 6, 2026 · 3:59 PM EST

Argenx Se (ARGX) Non Operating Income (2019 - 2021)

Updated

Argenx Se (ARGX) recorded Non Operating Income of -$944,000 in FY2021, compared with -$1.5 million in FY2020.

Analysis

Argenx Se (ARGX) Non Operating Income (2019 - 2021) Analysis & Trends

  • Per Business Quant data, ARGX's Non Operating Income was -$1.5 million in FY2020 and $15.99 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Argenx Se 56.96 Bn 56.96 Bn 1.56 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -420,000.00
Dec 31, 2020 320,725.97
Mar 31, 2020 -3.59 Mn
Dec 31, 2019 3.86 Mn
API Access

Argenx Se Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARGX&period=max&api_key=YOUR_API_KEY